| Application number | Title of the application | Filing Date | Status |
|---|
| 09/831124 | Method for preventing increased iridial pigmentation during prostaglandin treatment | Jul 22, 2001 | Abandoned |
Array
(
[id] => 6590756
[patent_doc_number] => 20020041907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Sophora japonica extracts for promoting desquamation/epidermal renewal of the skin and/or combating skin aging'
[patent_app_type] => new
[patent_app_number] => 09/906734
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20020041907.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906734
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906734 | Sophora japonica extracts for promoting desquamation/epidermal renewal of the skin and/or combating skin aging | Jul 17, 2001 | Abandoned |
Array
(
[id] => 6408385
[patent_doc_number] => 20020037884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Topical composition comprising ciprofloxacin and hydrocortisone'
[patent_app_type] => new
[patent_app_number] => 09/906325
[patent_app_country] => US
[patent_app_date] => 2001-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4885
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037884.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906325
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906325 | Topical composition comprising ciprofloxacin and hydrocortisone | Jul 15, 2001 | Abandoned |
Array
(
[id] => 6289278
[patent_doc_number] => 20020054892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Ultrasonic control of crystallisation'
[patent_app_type] => new
[patent_app_number] => 09/902292
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8660
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20020054892.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902292 | Ultrasonic control of crystallisation | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6774680
[patent_doc_number] => 20030018018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea'
[patent_app_type] => new
[patent_app_number] => 09/902389
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2869
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018018.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902389
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902389 | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6439794
[patent_doc_number] => 20020128264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Methods for treatment of conditions affected by activity of multidrug transporters'
[patent_app_type] => new
[patent_app_number] => 09/900297
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13544
[patent_no_of_claims] => 147
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128264.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900297
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900297 | Methods for treatment of conditions affected by activity of multidrug transporters | Jul 5, 2001 | Abandoned |
Array
(
[id] => 6510655
[patent_doc_number] => 20020025952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Combinations of statins, estrogens and estrogenic agents'
[patent_app_type] => new
[patent_app_number] => 09/896632
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10676
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025952.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896632 | Combinations of statins, estrogens and estrogenic agents | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6033442
[patent_doc_number] => 20020019373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Combinations of bisphosphonates and estrogenic agents'
[patent_app_type] => new
[patent_app_number] => 09/896154
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9434
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019373.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896154
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896154 | Combinations of bisphosphonates and estrogenic agents | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6000612
[patent_doc_number] => 20020028792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Combinations of bisphosphonates, estrogens and estrogenic agents'
[patent_app_type] => new
[patent_app_number] => 09/896219
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10668
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028792.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896219
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896219 | Combinations of bisphosphonates, estrogens and estrogenic agents | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6476937
[patent_doc_number] => 20020022613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Methods of treating prosthesis-related bone degeneration'
[patent_app_type] => new
[patent_app_number] => 09/896225
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9044
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022613.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896225
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896225 | Methods of treating prosthesis-related bone degeneration | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6637101
[patent_doc_number] => 20020086865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Use of growth hormone secretagogues for stimulating or increasing appetite'
[patent_app_type] => new
[patent_app_number] => 09/893014
[patent_app_country] => US
[patent_app_date] => 2001-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16126
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086865.pdf
[firstpage_image] =>[orig_patent_app_number] => 09893014
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/893014 | Use of growth hormone secretagogues for stimulating or increasing appetite | Jun 26, 2001 | Abandoned |
Array
(
[id] => 6344077
[patent_doc_number] => 20020035106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Use of potassium channel agonists for reducing fat food consumption'
[patent_app_type] => new
[patent_app_number] => 09/891691
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8958
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035106.pdf
[firstpage_image] =>[orig_patent_app_number] => 09891691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/891691 | Use of potassium channel agonists for reducing fat food consumption | Jun 25, 2001 | Abandoned |
Array
(
[id] => 6291891
[patent_doc_number] => 20020055529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Method for treating alzheimer\'s disease'
[patent_app_type] => new
[patent_app_number] => 09/888592
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 5639
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055529.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888592
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888592 | Method for treating alzheimer's disease | Jun 25, 2001 | Abandoned |
Array
(
[id] => 6210034
[patent_doc_number] => 20020072517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Substituted cyclic amine metalloprotease inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/888759
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33503
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072517.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888759
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888759 | Substituted cyclic amine metalloprotease inhibitors | Jun 24, 2001 | Abandoned |
Array
(
[id] => 7001092
[patent_doc_number] => 20010053795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'Paradoxical pharmacology'
[patent_app_type] => new
[patent_app_number] => 09/885183
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7338
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053795.pdf
[firstpage_image] =>[orig_patent_app_number] => 09885183
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/885183 | Paradoxical pharmacology | Jun 19, 2001 | Abandoned |
Array
(
[id] => 6861666
[patent_doc_number] => 20030092674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Tricyclic rantes receptor ligands'
[patent_app_type] => new
[patent_app_number] => 09/881559
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7333
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881559 | Tricyclic rantes receptor ligands | Jun 13, 2001 | Abandoned |
| 09/880624 | Adrenal enzyme inhibitors | Jun 11, 2001 | Abandoned |
| 09/720942 | Treatment of airborne microorganisms | Jun 7, 2001 | Abandoned |
Array
(
[id] => 6096541
[patent_doc_number] => 20020052312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 09/867142
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052312.pdf
[firstpage_image] =>[orig_patent_app_number] => 09867142
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/867142 | Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists | May 28, 2001 | Abandoned |
| 09/856862 | Drugs | May 24, 2001 | Abandoned |